Infections in sickle cell anemia: pathogenesis and control

Area of Science:

• Pediatric Immunology
• Infectious Diseases
• Hematology

Background:

• Homozygous sickle cell disease (SCD) significantly impairs splenic function, leading to profound immune deficits.
• Young children with SCD are at immense risk for severe pyogenic infections due to combined splenic dysfunction and immunologic immaturity.

Purpose of the Study:

• To evaluate the effectiveness of pneumococcal vaccines in children under five with SCD.
• To assess the antibody response to pneumococcal vaccines in young children with SCD.
• To investigate the potential of prophylactic antibiotic regimens for preventing pneumococcal sepsis in asplenic hosts.

Main Methods:

• Analysis of existing data on pneumococcal vaccine efficacy in children with SCD.
• Assessment of antipneumococcal antibody responses in children under two with SCD.
• Review of reported pneumococcal vaccine failures in children with SCD.

Main Results:

• Pneumococcal vaccines provide only modest protection in children with SCD younger than five years.
• Antipneumococcal antibody responses are poor in children with SCD under two years of age.
• All documented pneumococcal vaccine failures occurred in children under three with SCD, caused by specific pneumococcal serotypes.

Conclusions:

• Children with SCD, particularly those under five, have a high risk of severe infections due to splenic dysfunction.
• Current pneumococcal vaccines are not fully effective in preventing infections in young children with SCD.
• The efficacy of prophylactic antibiotics for preventing pneumococcal sepsis in asplenic children with SCD remains undetermined and requires rigorous scientific investigation.